Monday, December 23, 2019
The US Food and Drug Administration on Monday announced the approval of a drug called ubrogepant for the acute treatment of migraine, which could be a new option for people who can't take or don't respond to migraine medications currently on the market.
from CNN.com - RSS Channel - HP Hero https://ift.tt/3728sWh
